SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0600-6.3%Nov 10 3:45 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Howard Williams12/28/2013 11:41:09 AM
1 Recommendation

Recommended By
Jack Russell

   of 13111
 
#1 for the week
*****************
http://www.dailyfinance.com/2013/12/28/ … this-week/

3 Humongous Health-Care Stocks This Week

by Keith Speights, The Motley Fool Dec 28th 2013 8:00AM
Updated Dec 28th 2013 8:02AM

This year will go down in the record books as one of the best ever for health-care stocks. And the year isn't ending on a disappointing note. Several health-care stocks experienced huge gains during the short holiday week. Here are the three biggest winners.

High C
Provectus Biopharmaceuticals stands out as the top health-care stock on our list. Shares skyrocketed 45% on momentum from an important "type C" meeting held with the U.S. Food and Drug Administration last week.

On Dec. 18, Provectus announced that it had met two days earlier with the FDA about a pathway to approval for the company's melanoma drug PV-10. There really wasn't much that the company could share about the meeting, but the news was enough to excite investors.

Provectus is gearing up [sic] for a phase 3 pivotal trial of PV-10 in treating melanoma, which received orphan drug designation from the FDA in 2011. An early stage trial of the drug in treating breast cancer has also been completed with another under way targeting liver cancer.
****************************************
The other two were Inovio Pharmaceuticals, up 32%, and United Therapeutics, up 29%.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News